The Impact of Opioid Prescription on the Occurrence and Outcome of Pneumonia: A Nationwide Cohort Study in South Korea

REFERENCES

1. 1.↵
   1. Risdahl JM,
   2. Khanna KV,
   3. Peterson PK,
   4. Molitor TW

   . Opiates and infection. J Neuroimmunol 1998;83(1-2):4-18.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Tong S,
   2. Amand C,
   3. Kieffer A,
   4. Kyaw MH

   . Trends in health care utilization and costs associated with pneumonia in the United States during 2008–2014. BMC Health Serv Res 2018;18(1):715.

   OpenUrlPubMed
3. 3.↵
   1. Olson G,
   2. Davis AM

   . Diagnosis and treatment of adults with community-acquired pneumonia. Jama 2020;323(9):885-886.

   OpenUrlPubMed
4. 4.↵
   1. Steffens C,
   2. Sung M,
   3. Bastian LA,
   4. Edelman EJ,
   5. Brackett A,
   6. Gunderson CG

   . The association between prescribed opioid receipt and community-acquired pneumonia in adults: a systematic review and meta-analysis. J Gen Intern Med 2020;35(11):3315-3322.

   OpenUrlPubMed
5. 5.↵
   1. Velly AM,
   2. Steele R,
   3. Karp I,
   4. Morenz E,
   5. Moulin D,
   6. Morales DR,
   7. et al

   . The impact of opioids on the incidence of community-acquired pneumonia: a large nested case-control study. Ann Epidemiol 2017;27(8):520.

   OpenUrl
6. 6.↵
   1. Park YJ,
   2. Yo C-H,
   3. Hsu W-T,
   4. Tsou EP-Y,
   5. Wang Y-C,
   6. Ling D-A,
   7. et al

   . Use of opioids and outcomes of pneumonia: results from the US nationwide in-patient sample. J Acute Med 2021;11(4):113.

   OpenUrlPubMed
7. 7.↵
   1. Benyamin R,
   2. Trescot AM,
   3. Datta S,
   4. Buenaventura RM,
   5. Adlaka R,
   6. Sehgal N,
   7. et al

   . Opioid complications and side effects. Pain Phys 2008;2s;11(3;2s):S105-S120.

   OpenUrl
8. 8.↵
   1. Plein LM,
   2. Rittner HL

   . Opioids and the immune system—friend or foe. Br J Pharmacol 2018;175(14):2717-2725.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Rittner HL,
   2. Roewer N,
   3. Brack A

   . The clinical (ir) relevance of opioid-induced immune suppression. Curr Opin Anaesthesiol 2010;23(5):588-592.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Eisenstein TK

    . The role of opioid receptors in immune system function. Front Immunol 2019;10:2904.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Oh TK,
    2. Jeon Y-T,
    3. Choi JW

    . Trends in chronic opioid use and association with 5-year survival in South Korea: a population-based cohort study. Br J Anaesth 2019;123(5):655-663.

    OpenUrlPubMed
12. 12.↵
    1. Kim J,
    2. Shin S-J,
    3. Yoon J,
    4. Kim H-S,
    5. Lee J-W,
    6. Kim Y-S,
    7. et al

    . Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort. Epidemiol Health 2022;44:e2022029.

    OpenUrlPubMed
13. 13.↵
    1. Von Elm E,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gøtzsche PC,
    6. Vandenbroucke JP

    ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370(9596):1453-1457.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Lee J,
    2. Lee JS,
    3. Park S-H,
    4. Shin SA,
    5. Kim K

    . Cohort profile: the National Health Insurance Service–national sample cohort (NHIS-NSC), South Korea. Int J Epidemiol 2017;46(2):e15-e15.

    OpenUrl
15. 15.↵
    1. Zin CS,
    2. Nazar NI,
    3. Rahman NSA,
    4. Ahmad WR,
    5. Rani NS,
    6. Ng KS

    . Patterns of initial opioid prescription and its association with short-term and long-term use among opioid-naïve patients in Malaysia: a retrospective cohort study. BMJ Open 2019;9(7):e027203.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Dang TT,
    2. Eurich DT,
    3. Weir DL,
    4. Marrie TJ,
    5. Majumdar SR

    . Rates and risk factors for recurrent pneumonia in patients hospitalized with community-acquired pneumonia: population-based prospective cohort study with 5 years of follow-up. Clin Infect Dis 2014;59(1):74-80.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Sharma N,
    2. Schwendimann R,
    3. Endrich O,
    4. Ausserhofer D,
    5. Simon M

    . Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national in-patient data. BMC Health Serv Res 2021;21(1):13-10.

    OpenUrlPubMed
18. 18.↵
    1. Yoon S-H,
    2. Kim J,
    3. Yoon S,
    4. Lee H-J

    . Current status of opioid prescription in South Korea using narcotics information management system. Korean J Pain 2024;37(1):41-50.

    OpenUrlPubMed
19. 19.↵
    1. Vozoris NT,
    2. Wang X,
    3. Fischer HD,
    4. Bell CM,
    5. O’Donnell DE,
    6. Austin PC,
    7. et al

    . Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J 2016;48(3):683-693.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Wiese AD,
    2. Griffin MR,
    3. Schaffner W,
    4. Stein CM,
    5. Greevy RA,
    6. Mitchel Jr EF,
    7. et al

    . Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med 2018;168(6):396-404.

    OpenUrlPubMed
21. 21.↵
    1. Shah V,
    2. Hoang N,
    3. Rodgers B,
    4. Dornbos IID,
    5. Eaton R,
    6. Pezzutti D,
    7. et al

    . The impact of preoperative opioids on outcomes in craniotomy patients. Neurosurgery 2019;66(Supplement 1):310-706.

    OpenUrl
22. 22.↵
    1. Kim S,
    2. Franklin P,
    3. Jin Y,
    4. Lee Y,
    5. Lii J,
    6. Franklin J,
    7. et al

    . Preoperative opioid use and short-term safety events following total knee replacement surgery. Osteoarthritis and Cartilage 2019;27:S516.

    OpenUrl
23. 23.↵
    1. Hamina A,
    2. Taipale H,
    3. Karttunen N,
    4. Tanskanen A,
    5. Tiihonen J,
    6. Tolppanen A-M,
    7. et al

    . Hospital-treated pneumonia associated with opioid use among community dwellers with Alzheimer’s disease. J Alzheimers Dis 2019;69(3):807-816.

    OpenUrlPubMed
24. 24.↵
    1. Tsukuura H,
    2. Nishimura K,
    3. Taniguchi H,
    4. Kondoh Y,
    5. Kimura T,
    6. Kataoka K,
    7. et al

    . Opioid use in end-of-life care in patients with interstitial pneumonia associated with respiratory worsening. J Pain Palliat Care Pharmacother 2013;27(3):214-219.

    OpenUrlPubMed
25. 25.↵
    1. Dowell D

    . CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recommendations and reports 2022;71.
26. 26.↵
    1. Cowan DT,
    2. Wilson-Barnett J,
    3. Griffiths P,
    4. Allan LG

    . A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med 2003;4(4):340-351.

    OpenUrlPubMed
27. 27.↵
    1. Saffier K,
    2. Colombo C,
    3. Brown D,
    4. Mundt MP,
    5. Fleming MF

    . Addiction Severity Index in a chronic pain sample receiving opioid therapy. J Subst Abuse Treat 2007;33(3):303-311.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Han T

    . Opioids in cancer and non‐cancer pain management in Korea: the past, present, and future. Eur J Pain 2001;5 Suppl A(SA):73-78.

    OpenUrlPubMed
29. 29.↵
    1. Kim MJ,
    2. Kim JY,
    3. Lim YH,
    4. Hong SJ,
    5. Jeong JH,
    6. Choi HR,
    7. et al

    . Actual situation and prescribing patterns of opioids by pain physicians in South Korea. Korean J Pain 2022;35(4):475-487.

    OpenUrlPubMed